|Slideshows|February 6, 2015

Slide Show: Measles & the MMR Vaccine

The Centers for Disease Control and Prevention (CDC) offers frequently asked questions (FAQs) about measles and the MMR vaccine.

Newsletter

Stay prepared and protected with the Infection Control Today newsletter, delivering essential updates, best practices, and expert insights for infection prevention professionals.

Subscribe

Related Content

Environmental service professional mopping in a hospital. (Adobe Stock 436088376 by TommyStockProject)

Why Visibly Clean Environments Can Still Create Infection Risks

ByBrodie Cook

July 24th 2026

Health care workers in Uganda (Image credit by author with AI)

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

ByBrenna Doran, PhD, MA, ACC, CIC, AL-CIP

July 23rd 2026

Sepsis concept represented by wooden letter tiles on a wooden table with glasses and a book (Adobe Stock 328579157by lexiconimages)

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

ByKaren Biesack, RHIA, CPHQ, CPPS

July 23rd 2026

Patients in Cambodia. (Image by Brayden Unger via AI)

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

ByBrenna Doran, PhD, MA, ACC, CIC, AL-CIP,Brayden Unger

July 22nd 2026

Hepatitis C written on a page. (Adobe Stock 112538011 by Vitalii Vodolazskyi)

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

ByInfection Control Today® Editorial Staff

July 21st 2026

Latest CME

Video

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Onyema Ogbuagu, MD, FACP, FIDSA; Jeffery A. Goad, PharmD, MPH; William P. Hanage, PhD

Multimedia

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Onyema Ogbuagu, MD, FACP, FIDSA

Slide Show: Measles & the MMR Vaccine

Related Content

Why Visibly Clean Environments Can Still Create Infection Risks

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

Atea Completes Enrollment in Phase 3 Hepatitis C Trial Evaluating Bemnifosbuvir and Ruzasvir

Latest CME

A Shield of Protection: Unmet Needs in COVID-19 Prevention and Control

Empowering HIV Management: Evidence-Based Prevention and Treatment Strategies

Trending on Infection Control Today

Why Visibly Clean Environments Can Still Create Infection Risks

The Discipline of Waiting: Uganda's 42-Day Ebola Countdown

Beyond the Alert: Why Sepsis Outcomes Come Down to What Happens After Detection

Special Feature. Three Days in Cambodia: What a Volunteer Saw Before He Had the Words

FDA Expands Cyclospora Outbreak Investigation to 9 States as Nearly 2,000 Confirmed Cases Highlight Challenges for Health Care Facilities